198 related articles for article (PubMed ID: 32467003)
1. Practice Patterns and Barriers in Botulinum Toxin Injection for the Treatment of Voice Disorders.
McGarey PO; Simpson CB; Daniero JJ
J Voice; 2022 Jan; 36(1):113-118. PubMed ID: 32467003
[TBL] [Abstract][Full Text] [Related]
2. Multidose Botulinum Toxin A for Intralaryngeal Injection: A Cost Analysis.
Gilbert MR; Young VN; Smith LJ; Rosen CA
J Voice; 2019 Mar; 33(2):159-161. PubMed ID: 29307768
[TBL] [Abstract][Full Text] [Related]
3. Current practices in the management of adductor spasmodic dysphonia.
Eskander A; Fung K; McBride S; Hogikyan N
J Otolaryngol Head Neck Surg; 2010 Oct; 39(5):622-30. PubMed ID: 20828529
[TBL] [Abstract][Full Text] [Related]
4. Common practices in botulinum toxin injection for spasmodic dysphonia treatment: A national survey.
Shoffel-Havakuk H; Rosow DE; Lava CX; Hapner ER; Johns MM
Laryngoscope; 2019 Jul; 129(7):1650-1656. PubMed ID: 30582627
[TBL] [Abstract][Full Text] [Related]
5. Outcomes of Onabotulinum Toxin A Treatment for Adductor Spasmodic Dysphonia and Laryngeal Tremor.
Patel PN; Kabagambe EK; Starkweather JC; Keller M; Gamsarian V; Lee J; Kulkarni V; Garrett CG; Francis DO
JAMA Otolaryngol Head Neck Surg; 2018 Apr; 144(4):293-299. PubMed ID: 29423509
[TBL] [Abstract][Full Text] [Related]
6. Botulinum toxin injection for abductor spasmodic dysphonia under cervical ultrasonography guidance.
Kunieda C; Nin F; Ohashi T; Hosokawa K; Watanabe Y; Ogawa T; Mori T; Kanazawa T
Auris Nasus Larynx; 2024 Apr; 51(2):361-364. PubMed ID: 37838568
[TBL] [Abstract][Full Text] [Related]
7. Laryngeal Botulinum Toxin Injection: Can It Be a Cause of Obstructive Sleep Apnea as an Adverse Effect?
Oktay Arslan B; Demirhan E; Uçar Hoşgör ZZ
J Voice; 2022 Jan; 36(1):119-122. PubMed ID: 32482493
[TBL] [Abstract][Full Text] [Related]
8. Life Threatening Delayed Complication of Botulinum Toxin Injection for Treatment of Spasmodic Dysphonia.
Yershov D; Partridge R
Prague Med Rep; 2020; 121(2):114-117. PubMed ID: 32553095
[TBL] [Abstract][Full Text] [Related]
9. Patient Experience Contributing to Outcomes of Laryngeal Botulinum Toxin Injection.
Rutt A; Kennelly KD; Martinez-Paredes JF
J Voice; 2022 Mar; 36(2):272-276. PubMed ID: 32553551
[TBL] [Abstract][Full Text] [Related]
10. Botulinum toxin management of spasmodic dysphonia (laryngeal dystonia): a 12-year experience in more than 900 patients.
Blitzer A; Brin MF; Stewart CF
Laryngoscope; 1998 Oct; 108(10):1435-41. PubMed ID: 9778279
[TBL] [Abstract][Full Text] [Related]
11. Effect of Botulinum Toxin and Surgery among Spasmodic Dysphonia Patients.
van Esch BF; Wegner I; Stegeman I; Grolman W
Otolaryngol Head Neck Surg; 2017 Feb; 156(2):238-254. PubMed ID: 27803079
[TBL] [Abstract][Full Text] [Related]
12. [Treatment of spasmodic dysphonia with botulinum toxin].
Klap P; Marion MH; Perrin A; Fresnel-Elbaz E
Ann Otolaryngol Chir Cervicofac; 1991; 108(8):477-82; discussion 482-3. PubMed ID: 1789624
[TBL] [Abstract][Full Text] [Related]
13. Quality of Life After Botulinum Toxin Injection in Patients With Adductor Spasmodic Dysphonia; a Systematic Review and Meta-analysis.
Faham M; Ahmadi A; Silverman E; Harouni GG; Dabirmoghaddam P
J Voice; 2021 Mar; 35(2):271-283. PubMed ID: 31477348
[TBL] [Abstract][Full Text] [Related]
14. Interarytenoid muscle botox injection for treatment of adductor spasmodic dysphonia with vocal tremor.
Kendall KA; Leonard RJ
J Voice; 2011 Jan; 25(1):114-9. PubMed ID: 20137891
[TBL] [Abstract][Full Text] [Related]
15. Laryngeal Botulinum Toxin Injection for Vocal Tremor: Utility of Concurrent Strap Muscle Injection.
Nelson RC; Silva Merea V; Tierney WS; Milstein C; Benninger MS; Bryson PC
Laryngoscope; 2019 Jun; 129(6):1433-1437. PubMed ID: 30588631
[TBL] [Abstract][Full Text] [Related]
16. Improved vocal quality and decreased vocal effort after botulinum toxin treatment for laryngeal dystonia.
Leung JS; Rosenbaum A; Holmberg J; Villarroel P; Napolitano C; Badía PI; Lagos-Villaseca A
Auris Nasus Larynx; 2024 Feb; 51(1):106-112. PubMed ID: 37365040
[TBL] [Abstract][Full Text] [Related]
17. Botulinum toxin treatment of false vocal folds in adductor spasmodic dysphonia: Functional outcomes.
Simpson CB; Lee CT; Hatcher JL; Michalek J
Laryngoscope; 2016 Jan; 126(1):118-21. PubMed ID: 26467807
[TBL] [Abstract][Full Text] [Related]
18. Considerations for initial dosing of botulinum toxin in treatment of adductor spasmodic dysphonia.
Rosow DE; Parikh P; Vivero RJ; Casiano RR; Lundy DS
Otolaryngol Head Neck Surg; 2013 Jun; 148(6):1003-6. PubMed ID: 23535709
[TBL] [Abstract][Full Text] [Related]
19. Quantitative laryngeal electromyography parameters may correlate with improved outcomes following botulinum toxin injection for spasmodic dysphonia.
Dwyer CD; Leclerc AA; Nandedkar SD; Young VN; Rosen CA
Muscle Nerve; 2021 Apr; 63(4):525-530. PubMed ID: 33382480
[TBL] [Abstract][Full Text] [Related]
20. Botulinum toxin injection for treatment of spasmodic dysphonia: experience at Srinagarind Hospital.
Srirompotong S; Saeseow P; Taweesaengsuksakul R; Kharmwan S; Srirompotong S
J Med Assoc Thai; 2006 Dec; 89(12):2077-80. PubMed ID: 17214059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]